BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: capecitabine|DRUG: ixabepilone
Sponsor: R-Pharm
Collaborators: National Cancer Institute (NCI)